Leo Brokerage’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$1.97M Buy
4,207
+239
+6% +$100K 0.23% 77
2023
Q1
$1.36M Buy
+3,968
New +$1.34M 0.2% 96
2022
Q2
$602K Sell
1,857
-2,999
-62% -$900K 0.16% 80
2022
Q1
$1.39M Buy
+4,856
New +$1.25M 0.22% 70
2021
Q3
$551K Sell
2,383
-77
-3% -$19K 0.1% 98
2021
Q2
$565K Sell
2,460
-1,024
-29% -$206K 0.11% 97
2021
Q1
$651K Buy
3,484
+791
+29% +$155K 0.18% 82
2020
Q4
$455K Buy
2,693
+182
+7% +$27.2K 0.15% 92
2020
Q3
$412K Buy
+2,511
New +$389K 0.17% 73

Other funds holding LLY

Leo Brokerage's LLY Position: Q2 2023 in Review

Leo Brokerage increased its Eli Lilly (LLY) stake by 6% in Q2 2023, buying an estimated $100K and bringing the position to 4,207 shares worth $1.97M. The position accounts for 0.23% of the portfolio, ranked #77.

Leo Brokerage first reported a position in LLY in Q3 2020 and has held it in 9 quarters since. 2,815 funds tracked by Wall St. Rank hold LLY as of Q2 2023.

  • Leo Brokerage held 4,207 shares of Eli Lilly worth $1.97M as of Q2 2023.
  • Leo Brokerage bought 239 Eli Lilly shares in Q2 2023, an estimated $100K.
  • Eli Lilly made up 0.23% of Leo Brokerage's portfolio in Q2 2023, its #77 holding.
  • Leo Brokerage first reported a position in Eli Lilly in Q3 2020 and has held it in 9 quarters since.
  • 2,815 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2023.

Based on Leo Brokerage's 13F filing for Q2 2023, filed 25 Jul 2023.